Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-07
2006-02-07
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S415000, C548S469000, C548S491000
Reexamination Certificate
active
06995184
ABSTRACT:
A subject-matter of the present invention is compounds of formula:and their preparation and the pharmaceutical compositions comprising them. These compounds are agonists for CB2cannabinoid receptors.
REFERENCES:
patent: 5532237 (1996-07-01), Gallant et al.
patent: 6013648 (2000-01-01), Rinaldi et al.
patent: WO 97/00860 (1997-01-01), None
patent: WO 01/28557 (2001-04-01), None
Eissenstat, et al. Aminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics, J. Med. Chem. vo. 38, pp. 3094-3105 (1995).
Barth Francis
Congy Christian
Guillaumont Carole
Rinaldi Murielle
Vasse Fabienne
Grazier Nyeemah
Gupta Balaram
Sanofi-Aventis
Solola Taofiq
LandOfFree
3-arylindole derivatives and their use as CB 2 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-arylindole derivatives and their use as CB 2 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-arylindole derivatives and their use as CB 2 receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3646269